← Leaderboards
Khalid A El Sayed
University Of Louisiana At Monroe
$1,685,985
Attributed
$1,685,985
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $420.5K · FY2006–23$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,685,985 · 9
By mechanism
P20$466,772 · 6
R41$454,755 · 1
R15$420,540 · 1
R21$343,918 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neoplasm Metastasis”
- Charles A Coltman · Southwest Oncology Group$110,022,912
- Timothy J Eberlein · Washington University$54,581,241
- Samuel A Wells · Duke University$31,864,469
- William George Nelson · Johns Hopkins University$31,104,956
- Zaver M Bhujwalla · Johns Hopkins University$30,433,864
- Leonidas C Platanias · University Of Illinois At Chicago$30,290,986
Research focus
Neoplasm MetastasisMalignant NeoplasmsFutureRecurrenceSurvival RateOralNatural ProductsDoseOperative Surgical ProceduresPrimary NeoplasmMouse ModelTumorMalignant Breast NeoplasmPreventNude MiceCancer RecurrenceRegimenNeoadjuvant TherapyExcisionAngiogenesisMalignant Neoplasm Of ProstateHydantoinsCancer CellHistopathology
Grant awards (11)
Targeting PCSK9 axis for castration-resistant prostate cancer recurrence suppression$161,499
R21 · FY2023 · CA · contact PI
Targeting PCSK9 axis for castration-resistant prostate cancer recurrence suppression$182,419
R21 · FY2022 · CA · contact PI
Oleocanthal functional food products for breast cancer recurrence control$54,756
R41 · FY2021 · CA · contact PI
Oleocanthal functional food products for breast cancer recurrence control$399,999
R41 · FY2020 · CA · contact PI
Design of novel c-Met inhibitors inspired by olive phenolics$420,540
R15 · FY2013 · CA · contact PI
MARINE NATURAL PRODUCTS AS ANTI-ANGIOGENIC AND ANTI-INVASIVE AGENTS$55,074
P20 · FY2009 · RR · contact PI
MARINE NATURAL PRODUCTS AS ANTI-ANGIOGENIC AND ANTI-INVASIVE AGENTS$124,116
P20 · FY2008 · RR · contact PI
MARINE NATURAL PRODUCTS AS ANTI-ANGIOGENIC AND ANTI-INVASIVE AGENTS$138,717
P20 · FY2007 · RR · contact PI
DEVELOPMENT OF MARINE MACROLIDES LATRUNCULINS AS ANGIOGENESIS MODULATORS$118,412
P20 · FY2006 · RR · contact PI
ANTICANCER AND ANTI-INFECTIVE METABILITES FOR SYMBIOTIC MARINE MICROORGANISMS$24,982
P20 · FY2006 · RR · contact PI
DEVELOPMENT OF THE MARINE MACROLIDES LATRUNCULINS$5,471
P20 · FY2004 · RR